Fundz

Mersana Therapeutics, Inc. reported raising $33.1 Million in an initial SEC Form D filing, from an offering of $33.1 Million

PRIVATEJun 24, 2016

Amount Raised

$33.1 Million

$33.1 Million sold, per SEC Form D (first sale Jun 24, 2016)

Round Type

Venture

CambridgeBiotechnologyHealth CareTherapeutics

Quick answer

Mersana Therapeutics raised $33.1 Million in a funding round, dated June 24, 2016. Mersana Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Mersana Therapeutics raise?
Mersana Therapeutics raised $33.1 Million in a funding round on June 24, 2016.
What does Mersana Therapeutics do?
Mersana Therapeutics, Inc. is a biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.
Where is Mersana Therapeutics based and how big is it?
Mersana Therapeutics is based in Cambridge, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Mersana Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Amicus Therapeutics raised $4.7M (Seed) on July 19, 2016.
  • Immunome Inc. raised $5.1M on July 14, 2016.
  • Oragenics raised $4.7M (Seed) on July 13, 2016.
  • Rezolute raised $5.4M on July 13, 2016.
  • Prelude Therapeutics Inc raised $5M on July 11, 2016.
  • ELIAS Animal Health, LLC raised $650K (Seed) on July 7, 2016.

Who to call at Mersana Therapeutics, and when

A new round usually means Mersana Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mersana Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mersana Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mersana Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mersana Therapeutics

Location

840 MEMORIAL DRIVE

Cambridge, Massachusetts, United States

About

Mersana Therapeutics, Inc. is a biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) for cancer treatment. Their innovative ADC platform enables the design of more effective cancer therapies. Mersana strives to deliver meaningful treatments to patients battling cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mersana Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mersana Therapeutics's next move

See what Strategic adds

Mersana Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.